Status:
COMPLETED
Lung Deposition Via Different Inhalation Devices
Lead Sponsor:
AstraZeneca
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to assess the deposition of budesonide to the lung after inhalation with 5 different devices and to relate the findings to in vitro properties of inhaled budesonide.
Eligibility Criteria
Inclusion
- Provision of informed consent prior to any study specific procedures
- BMI between 18 and 30 kg/m2
- Non-smokers/non-snuffers
Exclusion
- Pregnant and/or lactating women
- Use of oral contraceptives or hormonal implants
- Known or suspected hypersensitivity to glucocorticosteroids, inhaled lactose, or other excipients in study drugs
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2009
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00975754
Start Date
September 1 2009
End Date
November 1 2009
Last Update
December 11 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Lund, Sweden